Comparison of thrice daily biphasic human insulin (30/70) versus basal detemir & bolus aspart in patients with poorly controlled type 2 diabetes mellitus – A pilot study

BACKGROUND & OBJECTIVES: Conventionally, biphasic human insulin (30/70, BHI) is used twice daily for the management of patients with diabetes. However, this regimen is suboptimal to control post-lunch and/or pre-dinner hyperglycaemia in some patients. This study was undertaken to compare the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Shanmugasundar, G., Bhansali, Anil, Walia, Rama, Dutta, Pinaki, Upreti, Vimal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307189/
https://www.ncbi.nlm.nih.gov/pubmed/22382187
http://dx.doi.org/10.4103/0971-5916.93428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307189/
https://www.ncbi.nlm.nih.gov/pubmed/22382187
http://dx.doi.org/10.4103/0971-5916.93428

Ejemplares similares